DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20150113
Published: 2017-02-08

Pregnancy with neurofibromatosis type II: the enigma continues

Ankita Pandey, Minakshi Tripathi, Simantini Bose, Balaji Jadhav, Y. S. Nandanwar

Abstract


Neurofibromatosis type II in pregnancy has variable presentations. The recurrence rate and bilaterality of CP angle tumour is very high. We present a case of bilateral schwanomma diagnosed in midpregnancy, for which patient was operated in second trimester and postpartum radiotherapy will now be given.

Keywords


Neurofibromatosis, Schwanomma, Autosomal dominant trait, Spinal anaesthesia

Full Text:

PDF

References


Children’s Tumour Foundation, New York. Latest news, 2015. Available at: www.ctf.org.

Weissman A, Jakobi P, Zaidise I, Drugan A. Neurofibromatosis and pregnancy. An update. J Reprod Med. 1993;38(11):890-6.

Torpy JM, Burke AE, Glass RM. Neurofibromatosis. JAMA. 2009;302:2170.

Babovic-Vuksamovic. (Expert Opinion). Neurofibromatosis. Mayo clinic. Rochester, Minn., 2012. Available at: http://www.mayoclinic.org/diseases-conditions/neurofibromatosis/multimedia/con-20027728. Accessed 26 November 2012.

Nebesio TD, Ming W, Chen S, Clegg T, Yuan J, Yang Y, et al. Neurofibromin deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration - implications for increased neurofibroma during pregnancy. Glia. 2007;55(5):527-36.

Ferner RE. The neurofibromatoses. Practical Neurol. 2010;10:82.

Dashe JF, Gilchrist JM. Overview of schwannomatosis, 2012. Available at: http://www.uptodate.com/index. Accessed 12 October 2012.